Tg Therapeutics (TGTX) Capital Expenditures Growth (1y) (2013 - 2026)
Tg Therapeutics (TGTX) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tg Therapeutics | 8.08 Bn | 8.00 Bn | 171.41 Mn | 104.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.00% |
| Dec 31, 2025 | 219.05% |
| Sep 30, 2025 | 233.33% |
| Dec 31, 2022 | -96.25% |
| Sep 30, 2022 | -94.94% |
| Mar 31, 2022 | -89.55% |
| Dec 31, 2021 | -48.39% |
| Sep 30, 2021 | -11.24% |
| Jun 30, 2021 | 288.89% |
| Mar 31, 2021 | -1.47% |
| Dec 31, 2020 | 355.88% |
| Sep 30, 2020 | 36.92% |
| Jun 30, 2020 | 150.00% |
| Mar 31, 2020 | 385.71% |
| Dec 31, 2019 | 466.67% |
| Sep 30, 2019 | 150.00% |
| Jun 30, 2019 | -47.06% |
| Mar 31, 2019 | -41.67% |
| Dec 31, 2018 | -96.34% |
| Sep 30, 2018 | 115.85% |